课题基金 / 基金详情

Protease-activated receptor (PAR)-2: A novel effector of mucosal healing in inflammatory bowel diseases.

Protease-activated receptor (PAR)-2: A novel effector of mucosal healing in inflammatory bowel diseases.
蛋白酶激活受体(PAR)-2:炎症性肠病粘膜愈合的新型效应器。
批准号:
417579
负责人:
Prico Larissa L
金额:
$4.92万
依托单位:
依托单位国家:
加拿大
项目类别:
Fellowship Programs
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-10-01 至 2022-10-01

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis, are chronic, relapsing and remitting diseases affecting ~250,000 Canadians. The cause of IBD is unknown and current drug therapies are often ineffective, have serious side effe
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金